TFX

Teleflex Incorporated (NYSE:TFX) is a global medical device company founded in 1943 and headquartered in Wayne, Pennsylvania. The company has evolved from its early industrial roots to become a specialized manufacturer of single-use medical devices serving critical care and surgical markets worldwide. Teleflex went public in 1980 and has built its business through organic growth and strategic acquisitions, including recent additions like Palette Life Sciences and the planned acquisition of BIOTRONIK's Vascular Intervention business. The company is currently undergoing a significant strategic transformation, planning to separate into two independent publicly traded entities to better focus each business on its distinct growth opportunities and operational requirements.